Blue Cross Blue Shield - Iowa Prior Authorization Lookup
Latest Blue Cross Blue Shield - Iowa prior authorization updates25
- Prior AuthClinical/Medical PolicyEff. 2026-08-28Intravenous Immune Globulin (IVIG) — indications and authorization criteriaThis section of the IVIG policy lists specific clinical indications and the authorization durations/criteria for intravenous immune globulin therapy for members of Blue Cross Blue Shield - Iowa. It affects providers requesting prior authorization for IVIG for the listed diagnoses.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-08-15Wegovy (semaglutide) — Supplemental Indications (cardiovascular risk reduction and MASH)Defines coverage, prior authorization documentation, prescriber specialty requirements, and medical necessity criteria for Wegovy (semaglutide) injection and tablet when used for cardiovascular risk reduction and metabolic dysfunction-associated steatohepatitis (MASH). Applies to Blue Cross Blue Shield - Iowa members where benefits exist.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-08-14Kineret (anakinra) — Coverage CriteriaDefines prior-authorization, documentation, prescriber specialty, and medical necessity criteria for Kineret (anakinra) for FDA-approved and compendial indications for Blue Cross Blue Shield - Iowa members.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-08-11Multiple Sclerosis — Disease‑Modifying TherapiesDefines prior authorization, preferred‑drug sequencing, and medical necessity criteria for disease‑modifying therapies for relapsing and other forms of multiple sclerosis for Blue Cross Blue Shield - Iowa members.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-08-05Kerendia (finerenone) — Coverage CriteriaThis policy governs prior authorization and medical necessity criteria for coverage of Kerendia (finerenone) for adults with chronic kidney disease and type 2 diabetes or heart failure, per Blue Cross Blue Shield - Iowa.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-08-01Formulary Medical Necessity ProgramDefines medical necessity requirements and prior authorization criteria for multiple outpatient prescription drugs subject to the payer's formulary medical necessity program; applies to providers submitting coverage requests to Blue Cross Blue Shield - Iowa (Wellmark).All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-31Enzyme Replacement Therapy (Coverage Criteria)Policy governing prior authorization and coverage criteria for FDA-approved enzyme replacement therapies for specified inherited/metabolic disorders for Blue Cross Blue Shield - Iowa members.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-29Esbriet (pirfenidone) for idiopathic pulmonary fibrosisDefines prior authorization, documentation, and medical necessity criteria for Esbriet (pirfenidone) use in members with idiopathic pulmonary fibrosis (IPF) for Blue Cross Blue Shield - Iowa.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-07-29Increlex (mecasermin) — Coverage Criteria for Severe Primary IGF-1 DeficiencyThis policy governs medical necessity criteria, prior authorization documentation, prescriber requirements, and continuation/initial approval rules for Increlex (mecasermin) in pediatric patients with severe primary IGF-1 deficiency or GH gene deletion with neutralizing antibodies to GH for Blue Cross Blue Shield - Iowa members.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-11Otezla (apremilast) prior authorization and coverage policyDefines medical necessity criteria, required documentation, prescriber specialty, quantity limits, dosing guidance, continuation criteria, and exclusions for coverage of Otezla (apremilast) for plaque psoriasis, psoriatic arthritis, Behçet's disease oral ulcers, and immune checkpoint inhibitor-related toxicity for Wellmark Blue Cross and Blue Shield.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-06Colony Stimulating FactorsPolicy governs prior authorization, preferred and targeted colony stimulating factor products, and coverage criteria for Blue Cross Blue Shield - Iowa members requesting CSF therapy.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-06Colony Stimulating FactorsDefines preferred short- and long-acting colony stimulating factor (CSF) products, exception criteria, documentation and prior authorization requirements for coverage, and clinical criteria for initial and continuation approval for selected products (notably Rolvedon). Affects prescribers and members under Blue Cross Blue Shield - Iowa benefit plans.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-06Lomitapide (Juxtapid) for homozygous familial hypercholesterolemia — Coverage CriteriaDefines medical necessity, prior authorization requirements, and documentation for Juxtapid (lomitapide) used as adjunct therapy in patients with homozygous familial hypercholesterolemia (HoFH). Applies to Wellmark/Blue Cross Blue Shield members covered under applicable contracts.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-04Cosentyx (secukinumab) drug policyDefines coverage, prior authorization requirements, documentation, prescriber specialties, and clinical criteria for Cosentyx (subcutaneous and intravenous formulations) for Wellmark/Blue Cross Blue Shield members.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-04Cosentyx (secukinumab) — Coverage Criteria and Prior AuthorizationDefines coverage, prior authorization requirements, required documentation, and clinical criteria for Cosentyx (subcutaneous and intravenous formulations) for multiple inflammatory dermatologic and rheumatologic indications for Wellmark Blue Cross and Blue Shield members.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-04Skyrizi (risankizumab-rzaa) coverage and prior authorization policyDefines clinical criteria, documentation, prescriber specialties, approval durations, continuation criteria, TB screening, quantity limits, dosing/admin guidance, and billing codes for risankizumab (Skyrizi) for plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis for Wellmark Blue Cross and Blue Shield - Iowa.All Blue Cross Blue Shield - Iowa updates
- Prior AuthReimbursement/Payment PolicyEff. 2026-06-03Corlanor (ivabradine) coverage and prior authorization policyGoverns coverage, prior authorization requirements, dosing, and quantity limits for Corlanor (ivabradine) for Blue Cross Blue Shield - Iowa members; applies where the benefit exists and member-specific contract terms allow.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-03Formulary Medical Necessity ProgramDefines medical necessity criteria and prior-authorization style requirements for non-site-specific outpatient formulary drugs for Blue Cross Blue Shield - Iowa members; applies to medications subject to the Formulary Medical Necessity Program not otherwise managed through drug-specific criteria.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-03Growth Hormone (somatropin and related products) — Coverage CriteriaCriteria and prior authorization requirements for coverage of growth hormone (somatropin and related products) for pediatric and adult indications under Wellmark (Blue Cross Blue Shield - Iowa). Applies to prescribers and prior authorization reviewers determining medical necessity.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-03Palynziq (pegvaliase-pqpzl) for phenylketonuria (PKU)Clinical coverage policy for use of Palynziq in adults with phenylketonuria (PKU); describes initial and continuation medical necessity criteria, documentation and prescribing requirements, quantity limits, and dosing guidance for providers and prior authorization reviewers.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-03Palynziq (pegvaliase-pqpzl) for phenylketonuria (PKU)Coverage criteria and prior authorization requirements for Palynziq (pegvaliase-pqpzl) for treatment of phenylketonuria in members of Wellmark/Blue Cross Blue Shield plans where benefits apply.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-06-03Romosozumab (Evenity) for Postmenopausal Osteoporosis — Coverage CriteriaCovers criteria, documentation, and prior authorization requirements for romosozumab (Evenity) in postmenopausal women at high risk for fracture for Wellmark Blue Cross and Blue Shield members.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-29ADHD and Narcolepsy Prior Authorization for Stimulants and Wakefulness AgentsDefines medical necessity and prior authorization requirements for stimulant and wakefulness medications used to treat ADHD, narcolepsy, hypersomnia, and related sleep disorders for Wellmark members.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-29Cimzia (certolizumab pegol) — prior authorization and coverage criteriaDefines prior authorization, coverage criteria, and documentation requirements for Cimzia (prefilled syringes and lyophilized powder) for Wellmark/Blue Cross Blue Shield members; affects prescribers and pharmacy/medical benefit claim reviewers.All Blue Cross Blue Shield - Iowa updates
- Prior AuthClinical/Medical PolicyEff. 2026-05-29Kineret (anakinra) drug coverageDefines prior authorization, documentation, prescriber specialty, and medical necessity criteria for Kineret (anakinra) for FDA-approved indications and specified compendial uses for Wellmark Blue Cross and Blue Shield members.All Blue Cross Blue Shield - Iowa updates
1–25 of 393
1 / 16
Tool Description
Search Blue Cross Blue Shield - Iowaprior authorization policies by drug name, procedure, or policy title. Results include any policy that mentions prior authorization requirements (drug coverage criteria, imaging guidelines, site-of-service rules) not just documents titled “prior authorization.” Every result links to a full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Filter by payer, specialty, policy type, or effective year; or search directly for a drug (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee arthroplasty”), or a policy number.
Coverage spans 110+ payers. Jump straight to the busiest prior-auth publishers: UnitedHealthcare, Cigna, Aetna, Anthem, and Centene. You can also browse the full policy updates feed.
Pair a prior-auth search with the billing code lookup to confirm the CPT or J-code on the claim, the payer lookup for plan footprint, and payer profiles for contacts and coverage context.
FAQ
Type a drug name (“Wegovy,” “Ozempic”), a procedure (“MRI,” “knee”), or a policy title into the search bar. Filter results by payer, specialty, policy type, or effective year. Open any result for the full policy page with clinical criteria, covered billing codes, documentation requirements, and effective dates.
Prior Authorization by Payer
Go deeper
Explore OpenPayer Data
Prior auth requirements change all the time. Keep up with every payer policy update in the live policy feed, or browse payers with prior authorization policies.
Toolbox
More OpenPayer Tools
- Billing Code LookupSearch CPT, HCPCS, J-codes, DRG, and dental codes by number or procedure name.
- Healthcare Provider & Facility LookupFind hospitals and healthcare facilities by name, taxonomy, facility type, ownership, or state.
- Health Insurance Payer LookupSearch national health insurance payers and health plans by name and state presence.
- Provider Taxonomy Code LookupSearch NUCC taxonomy codes by code, specialty, grouping, or classification.
- CPT Modifier LookupSearch CPT modifiers by code or name — descriptions, when to use them, and payer policy context.
- Timely Filing LookupFind payer timely filing policies: claim deadlines, corrected claim windows, and appeal timeframes.
- Coverage Criteria LookupSearch payer coverage criteria and medical necessity requirements by drug, procedure, or payer.
- Payer Contact DirectoryClaims, prior authorization, provider services, and appeals contacts for health insurance payers.
Published by
Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.